Alessandro Repici, Director of Digestive Endoscopy Unit at Humanitas Research Hospital, Expert Member of the National Institute of Health of the Italian Government, shared a post on LinkedIn:
“Multi-cancer early detection (MCED) blood tests continue to face clinical validation challenges after Grail’s Galleri test failed to meet its primary endpoint in the large NHS-Galleri trial. As a matter of fact, colonscopy still remains the most robust diagnostic method to prevent colorectal cancer.”
Other articles about MCED on OncoDaily.